Long-COVID mystery: new study aims to decode patient subtypes
NCT ID NCT07356570
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 150 adults with long-COVID to group them by their symptoms and link those groups to lab results. The goal is to find patterns that could help doctors predict outcomes and discover new treatments. Participants will have their health data and blood samples analyzed over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-ACUTE COVID-19 SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Henry Gabrielle-HCL
RECRUITINGSaint-Genis-Laval, 69230, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Service Pneumologie aigue spécialisée et cancérologie thoracique
RECRUITINGPierre-Bénite, 69 495, France
Contact Phone: •••-•••-•••• Email: •••••@•••••